4//SEC Filing
Arcadia Biosciences, Inc. 4
Accession 0001209191-15-070366
$RKDACIK 0001469443operating
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:28 PM ET
Size
9.5 KB
Accession
0001209191-15-070366
Insider Transaction Report
Form 4
Lu Zhongjin
VP Product Development
Transactions
- Sale
Common Stock
2015-09-11$4.92/sh−1,068$5,253→ 14,760 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-11−2,958→ 0 totalExercise: $0.44Exp: 2015-12-31→ Common Stock (2,958 underlying) - Exercise/Conversion
Common Stock
2015-09-11$0.44/sh+2,958$1,302→ 15,828 total
Footnotes (3)
- [F1]The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person on June 14, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The option is fully exercisable as of the date hereof.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001469443
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:28 PM ET
- Size
- 9.5 KB